Chattem Includes Technology, Licensing Deals As Expansion Options

Chattem is ready to pursue technology acquisitions or licensing deals within health and beauty, and likely will make a move within the next few years, according to CEO Zan Guerry

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet